Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Highly Potent API Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific ...

The "Asia-Pacific Highly Potent API Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific highly potent API market is projected to ...

NewswireToday - /newswire/ - Greenville, NC, United States, 11/10/2011 - Metrics Inc. now offers neat active pharmaceutical ingredient (API) capsule filling in its state-of-the-art potent and ...

"Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033" report ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

RIVERVIEW, Michigan, Dec. 8, 2020 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced plans to ...

DUBLIN, Jan. 18, 2023 /PRNewswire/ -- The "Small and Midsize Biopharma Perspective on the Highly Potent API Manufacturing Market" report has been added to ResearchAndMarkets.com's offering. Small and ...

Latest plans include construction of a 600 sq. ft. conjugation facility in St. Louis. SAFC plans to construct a cGMP highly potent active pharmaceutical ingredients (HPAPIs) conjugation suite at its ...

EAST RUTHERFORD, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), ...